Verrica Pharmaceuticals (VRCA) Inventory (2023 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Inventory of $2.0 million for Q1 2026, down 19.72% year-over-year from $2.5 million in Q1 2025, and down 11.72% quarter-over-quarter from $2.2 million in Q4 2025.
Verrica Pharmaceuticals (VRCA) Inventory (2023 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Inventory history runs 4 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- In Q1 2026, Inventory fell 19.72% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (down 19.72% YoY), while the FY2025 annual figure was $2.2 million, down 9.22% from the prior year.
- Inventory for Q1 2026 stood at $2.0 million, down from $2.2 million in the prior quarter.
- The five-year high for Inventory was $2.7 million in Q2 2024, with the low at $279000.0 in Q3 2023.
- The 4-year median for Inventory is $2.5 million (2025), against an average of $2.1 million.
- The sharpest annual moves came in 2024 and 2026: Inventory surged 826.16% in 2024, then dropped 19.72% in 2026.
- Verrica Pharmaceuticals' Inventory stood at $1.0 million in 2023, then surged by 141.0% to $2.5 million in 2024, then fell by 9.22% to $2.2 million in 2025, then decreased by 11.72% to $2.0 million in 2026.
- Business Quant data shows VRCA's Inventory at $2.0 million in Q1 2026, $2.2 million in Q4 2025, and $2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | Verrica Pharmaceuticals | 104.71 Mn | 93.51 Mn | - | 2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.71 Mn |
| Mar 31, 2026 | 1.97 Mn |
| Dec 31, 2025 | 2.24 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 2.46 Mn |
| Dec 31, 2024 | 2.46 Mn |
| Sep 30, 2024 | 2.58 Mn |
| Jun 30, 2024 | 2.70 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 1.02 Mn |
| Sep 30, 2023 | 279,000.00 |